Tarsus ex-officer plans $3.8M stock sale

Tarsus Pharmaceuticals, Inc. (TARS) received a notice of proposed sale of common stock under Rule 144.

Rhea-AI Filing Summary

Tarsus Pharmaceuticals, Inc. (TARS) received a notice of proposed sale of common stock under Rule 144. Former officer Aziz A. Mottiwala, through Fidelity Brokerage Services LLC, plans to sell 53,043 shares of common stock, expected to be issued from a stock option exercise on 08/19/2026. The filing lists an aggregate market value of $3,819,096.00 for the shares to be sold and 43,882,996 shares of Tarsus common stock outstanding on the NASDAQ.

Key Figures

Shares to be sold: 53,043 shares Aggregate market value: $3,819,096.00 Shares outstanding: 43,882,996 shares +1 more

4 metrics

Shares to be sold 53,043 shares Common stock proposed to be sold under Rule 144

Aggregate market value $3,819,096.00 Aggregate market value of 53,043 shares to be sold

Shares outstanding 43,882,996 shares Tarsus common stock outstanding as listed in the notice

Planned option exercise date 08/19/2026 Date tied to stock option exercise and proposed sale

Key Terms

Rule 144, stock option exercise, aggregate market value, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 08/19/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 53043 | 3819096.00 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for Aziz A. Mottiwala"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale is disclosed for Tarsus Pharmaceuticals (TARS) in this Form 144?

The notice reports a proposed sale of 53,043 Tarsus (TARS) common shares by former officer Aziz A. Mottiwala. The shares are tied to a stock option exercise on 08/19/2026, with Fidelity Brokerage Services LLC acting as broker.

What is the aggregate market value of TARS shares covered by this Form 144?

The filing lists an aggregate market value of $3,819,096.00 for the 53,043 Tarsus (TARS) shares proposed for sale. This value reflects the seller’s notice under Rule 144 for these securities.

How many Tarsus Pharmaceuticals (TARS) shares are outstanding in this notice?

The Form 144 states that 43,882,996 shares of Tarsus (TARS) common stock are outstanding. This figure is presented as context for the 53,043 shares proposed to be sold under Rule 144.

Who is the selling security holder in the Tarsus (TARS) Form 144 filing?

The selling security holder is Aziz A. Mottiwala, identified as a former officer of Tarsus Pharmaceuticals (TARS). Fidelity Brokerage Services LLC is named as the broker handling the proposed sale of the shares.

On which market are the Tarsus (TARS) shares in this Form 144 listed?

The shares referenced in the notice are listed on NASDAQ. The Form 144 covers a proposed Rule 144 sale of 53,043 Tarsus (TARS) common shares associated with a stock option exercise dated 08/19/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 02:28 PM Accepted by SEC EDGAR 08/19/2026 - 02:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001788542
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tarsus Pharmaceuticals, Inc.
SEC File Number	001-39614
Address of Issuer	15440 LAGUNA CANYON ROAD IRVINE CALIFORNIA 92618
Phone	(949) 409-9820
Name of Person for Whose Account the Securities are To Be Sold	Mottiwala Aziz
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	53043	3819096.00	43882996	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	Stock Option Exercise	Issuer			53043	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Corey Walter, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Aziz A. Mottiwala
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)